Clinical Guidelines and Standards · Guidelines by Clinical Area

Obstetric Care Consensus No. 7: Placenta Accreta Spectrum

American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine

Published December 2018 Obstetrics & Gynecology
DOI 10.1097/AOG.0000000000002983 PMID 30461695

RRM Academy Synopsis

Placenta accreta spectrum risk rises with each prior cesarean

The chance of placenta accreta spectrum rises with each prior cesarean delivery. Two obstetric groups said so in a 2018 consensus statement. It covers risks, imaging, delivery plans and ways to save the uterus. Most evidence comes from observational studies and expert opinion.

Key Findings

  • In a systematic review, placenta accreta spectrum occurred in 0.3% of women with one previous cesarean delivery and in 6.74% of women with five or more.
  • For women with placenta previa, accreta risk climbed from 3% at the first cesarean to 11%, 40%, 61%, and 67% by the fifth or more.
  • Across 23 studies and 3,707 pregnancies, a systematic review found ultrasound had 90.72% sensitivity (95% CI, 87.2–93.6) and 96.94% specificity (95% CI, 96.3–97.5%).
  • The largest expectant management series found hysterectomy was needed in 22% (36/167) of women after expectant management was tried. Severe morbidity occurred in 6% (10/167).
  • The committee suggests scheduled delivery at 34 0/7–35 6/7 weeks for a stable patient. About one half of women beyond 36 weeks need emergency delivery for hemorrhage.

Interpretation

This consensus statement gathers published evidence and expert opinion. The authors say few randomized trials exist. Most information comes from cohort studies, case series, and expert opinion. The ultrasound accuracy figures come from expert centers. They may overestimate accuracy, since most women studied had major risk factors and readers knew the high risk in advance. Uterus-sparing care and expectant management rest on small case series. The committee calls both investigational and advises them only for carefully selected cases.

RRM Context

Restorative reproductive medicine treats uterine history as key information. The statement lists past uterine surgery and Asherman syndrome as risk factors. Its most favored hypothesis is a flaw where the womb lining meets the muscle. Protecting the uterus is a restorative goal.

Abstract

Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial-myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.

Topics

By this author

Related research

Clinical Guidelines and Standards › Guidelines by Clinical Area › Obstetric Guidelines · Birth and Delivery › Birth Outcomes › Maternal Morbidity · Diagnostics › Ultrasound › Transvaginal Ultrasound
PMID 30461695 30461695 DOI 10.1097/AOG.0000000000002983 10.1097/AOG.0000000000002983 American College of Obstetricians and Gynecologists et al. 2018, American College of Obstetricians and Gynecologists 2018